Cyclerion Therapeutics (CYCN) Enterprise Value (2019 - 2025)
Historic Enterprise Value for Cyclerion Therapeutics (CYCN) over the last 7 years, with Q3 2025 value amounting to -$4.6 million.
- Cyclerion Therapeutics' Enterprise Value fell 5905.29% to -$4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.6 million, marking a year-over-year decrease of 5905.29%. This contributed to the annual value of -$3.2 million for FY2024, which is 5731.08% up from last year.
- As of Q3 2025, Cyclerion Therapeutics' Enterprise Value stood at -$4.6 million, which was down 5905.29% from -$3.0 million recorded in Q2 2025.
- In the past 5 years, Cyclerion Therapeutics' Enterprise Value registered a high of -$2.9 million during Q3 2024, and its lowest value of -$70.4 million during Q2 2021.
- Its 5-year average for Enterprise Value is -$20.6 million, with a median of -$7.6 million in 2023.
- As far as peak fluctuations go, Cyclerion Therapeutics' Enterprise Value skyrocketed by 8256.78% in 2023, and later crashed by 5905.29% in 2025.
- Over the past 5 years, Cyclerion Therapeutics' Enterprise Value (Quarter) stood at -$54.0 million in 2021, then skyrocketed by 75.2% to -$13.4 million in 2022, then skyrocketed by 43.42% to -$7.6 million in 2023, then skyrocketed by 57.31% to -$3.2 million in 2024, then tumbled by 41.34% to -$4.6 million in 2025.
- Its last three reported values are -$4.6 million in Q3 2025, -$3.0 million for Q2 2025, and -$3.6 million during Q1 2025.